CAMP4 Therapeutics Corp. (CAMP)
4.15
-0.02
(-0.48%)
USD |
NASDAQ |
Sep 22, 16:00
4.15
0.00 (0.00%)
After-Hours: 20:00
CAMP4 Therapeutics Total Liabilities (Quarterly) : 94.12M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 94.12M |
| March 31, 2026 | 74.56M |
| December 31, 2025 | 70.10M |
| September 30, 2025 | 27.73M |
| June 30, 2025 | 11.29M |
| March 31, 2025 | 11.20M |
| Date | Value |
|---|---|
| December 31, 2024 | 15.16M |
| September 30, 2024 | 18.19M |
| June 30, 2024 | 14.91M |
| March 31, 2024 | |
| December 31, 2023 | 16.53M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| MannKind Corp. | 799.50M |
| Ocugen, Inc. | 140.76M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 93.43M |
| Shareholders Equity (Quarterly) | -0.693M |
| Debt to Equity Ratio | -3.423 |
| Current Ratio | 4.703 |
| Net Debt Paydown Yield | 0.49% |